Bellicum Pharmaceuticals Inc. (BLCM) |
|
0.8835 -0.081 (-8.45%)
|
11-11 16:00 |
|
Open: |
0.96 |
Pre. Close: |
0.965 |
|
High:
|
0.96 |
Low:
|
0.87 |
|
Volume:
|
522,783 |
Market Cap:
|
44M |
|
|
|
|
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.962 - 0.967 |
0.967 - 0.971 |
|
Low:
|
0.858 - 0.864 |
0.864 - 0.869 |
|
Close:
|
0.872 - 0.881 |
0.881 - 0.888 |
|
Technical analysis |
as of: 2019-11-11 4:30:31 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 1.38 One year: 1.72 |
| Support: |
Support1: 0.72 Support2: 0.60 |
| Resistance: |
Resistance1: 1.18 Resistance2: 1.47 |
| Pivot: |
0.96  |
| Moving Average: |
MA(5): 1.05 MA(20): 0.92
MA(100): 1.23 MA(250): 2.44 |
| MACD: |
MACD(12,26): 0.02 Signal(9): 0.01 |
| Stochastic oscillator: |
%K(14,3): 26.72 %D(3): 42.42 |
| RSI: |
RSI(14): 46.03 |
| 52-week: |
High: 5.44 Low: 0.72 Change(%): -78.8 |
| Average Vol(K): |
3-Month: 86713 10-Days: 134662 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.BLCM has closed above bottom band by 39.2%. Bollinger Bands are 51.1% wider than normal. The large width of the bands suggest high volatility as compared to BLCM's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Mon, 24 Dec 2018 15:08:00 +0000
Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA
Tue, 11 Dec 2018 14:22:00 +0000
Novan Announces Top-Line Data From Mid-Stage Molluscum Study
Tue, 24 Apr 2018 15:00:00 +0000
Is Bellicum Pharmaceuticals, Inc. a Buy?
Thu, 12 Apr 2018 15:37:00 +0000
FDA Lifts Clinical Hold on Bellicum's (BLCM) T Cell Therapy
Thu, 12 Apr 2018 13:55:00 +0000
Company News For Apr 12, 2018
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
